Abstract:The increasing incidence of bladder cancer and its high rate of recurrence over a 5-year period necessitate the need for diagnosis and surveillance amelioration. Cystoscopy and urinary cytology are the current tools, and molecular techniques such as BTA stat, NMP22, survivin mRNA, and urovysion FISH have attracted attention; however, they suffer from insufficient sensitivity or specificity. We developed a novel microfluidic approach for harvesting intact urinary-exfoliated tumor cells (UETC), either individually or in clusters, in a clean and segregated environment, which is crucial to minimize cross-contamination and misreads. To reliably and accurately identify UETC, our quantitative immunoassay involved concurrent use of two oncoproteins CK20 and CD44v6 antigen. CK20 is an intermediate filament protein overexpressed in urothelial tumors, and CD44v6 is a membrane adhesion molecule closely associated with cell invasion, tumor progression, and metastatic spread. Single-cell whole-genome sequencing on 12 captured UETCs and copy number alteration analysis showed that 11/12 (91.7%) of the immunofluorescence-identified UETCs possessed genomic instability. A total of 79 patients with bladder cancer and 43 age-matched normal controls (NC) were enrolled in the study. We detected considerably higher UETC counts in patients with bladder cancer versus the NC group [53.3 (10.7-1001.9) vs. 0.0 (0-3.0) UETCs/10 mL; P < 0.0001]. For bladder cancer detection, a stratified 10-fold cross-validation of training data reveals an overall predictive accuracy of 0.84 [95% confidence interval (CI), 0.76-0.93] with an 89.8% (95% CI, 71.5%-86.4%) for sensitivity and 71.5% (95% CI, 59.7%-83.3%) for specificity. Overall, the microfluidic immunoassay demonstrates increased sensitivity and specificity compared with other techniques for the detection of bladder cancer.Significance: A unique and promising diagnostic assay for bladder cancer is proposed with potential clinical utility as a complement for cytology. Cancer Res; 78(14); 4073-85. ©2018 AACR.

Laser Capture Microdissection Combined with RNA in Vitro Linear Amplification Detecting the Relevant Genes of Bladder Cancer

Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer

Microfluidic Assaying of Circulating Tumor Cells and its Correlation with Muscle Invasiveness and Tumor Grade of Urothelial Bladder Cancer

Improvement of Tissue Preparation for Laser Capture Microdissection: Application for Cell Type-Specific Mirna Expression Profiling in Colorectal Tumors

Application of laser capture microdissection to capture pure cells in lung cancer and their paired normal lung tissues

Classification of formalin-fixed bladder cancer cells with laser tweezer Raman spectroscopy

Differential Gene Expression Profiling in Aggressive Bladder Transitional Cell Carcinoma Compared to the Adjacent Microscopically Normal Urothelium by Microdissection-Smart Cdna PCR-SSH.

Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray.

Construction of Transcriptome Profiling of Cancerous Parenchyma Cells Using Laser Capture Microdisscction and Gene-Chip Technology

An Application of Laser Capture Microdissection to Isolate the Pure Atrial Cells

Establishment of urinary micro-RNA detection method and its application in diagnosis of bladder cancer

Clinical study on diagnostic utility of Survivin-molecular beacons in bladder cancer

A Simple Method for Assessment of RNA Integrity in Laser Capture Microdissection Samples

Primary application study in early diagnosis of bladder cancer by survivin molecular beacons.

Detection of Urothelial Bladder Carcinoma via Microfluidic Immunoassay and Single-Cell DNA Copy-Number Alteration Analysis of Captured Urinary-Exfoliated Tumor Cells

Preliminary study of diagnostic utility of molecular beacons in bladder cancer.

A non-invasive genomic diagnostic method for bladder cancer using size-based filtration and microchip electrophoresis

Collaborating single-cell and bulk RNA sequencing for comprehensive characterization of the intratumor heterogeneity and prognostic model development for bladder cancer

Photostable Cascade Activatable Peptide Self‐assembly on a Cancer Cell Membrane for High‐Performance Identification of Human Bladder Cancer

The clinical value of rapidly detecting urinary exosomal lncRNA RMRP in bladder cancer with an RT-RAA-CRISPR/Cas12a method

Robust Acquisition of Spatial Transcriptional Programs in Tissues with Immunofluorescence-Guided Laser Capture Microdissection.